Skip to main content

and
  1. Article

    Open Access

    Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C

    C Gómez, B Perdiguero, V Jimenez, A Filali-Mouhim, K Ghneim, E Haddad in Retrovirology (2012)

  2. Article

    Open Access

    Antigen-specific T lymphocyte responses elicited by a DNA – MVA HIV CN54gp140 immunization regime are significantly altered by the TLR4 adjuvant GLA

    PF McKay, AV Cope, J Swales, S Joseph, M Esteban, R Tatoud, D Carter in Retrovirology (2012)

  3. Article

    Open Access

    Immune responses triggered by HIV/AIDS vaccine candidates, derived from MVA-B, with deletions in several immune regulatory genes

    J García-Arriaza, P Arnáez, CE Gómez, M Esteban in Retrovirology (2012)

  4. Article

    Open Access

    Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses

    SL Hulot, BT Korber, G Pantaleo, J Tartaglia, B Jacobs, B Perdiguero in Retrovirology (2012)

  5. Article

    Open Access

    P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitro

    E Quakkelaar, A Redeker, N Loof, B Perdiguero, P Heinen, J Nieto in Retrovirology (2009)

  6. Article

    Open Access

    P17-07. Insertion of a vaccinia virus host range (hr) gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens

    JL Najera, CE Gomez, J Garcia-Arriaza, M Esteban in Retrovirology (2009)

  7. Article

    Open Access

    P02-04. Multimeric soluble CD40 ligand efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus strains

    J Najera, C Gomez, M Esteban in Retrovirology (2009)